...
首页> 外文期刊>Hepatology research: the official journal of the Japan Society of Hepatology >Combination of neutrophil-to-lymphocyte ratio and early des--carboxyprothrombin change ratio as a useful predictor of treatment response for hepatic arterial infusion chemotherapy against advanced hepatocellular carcinoma
【24h】

Combination of neutrophil-to-lymphocyte ratio and early des--carboxyprothrombin change ratio as a useful predictor of treatment response for hepatic arterial infusion chemotherapy against advanced hepatocellular carcinoma

机译:中性粒细胞与淋巴细胞比和早期des - 羧基丙蛋白变化比的组合作为肝动脉输注化疗治疗晚期肝细胞癌的有用预测因子

获取原文
获取原文并翻译 | 示例
           

摘要

AimHepatic arterial infusion chemotherapy (HAIC) is a potent therapeutic option for advanced hepatocellular carcinoma (HCC). However, there are few known predictive factors of treatment response to HAIC. We clarified the most accurate predictive factors early on in treatment.
机译:Aimhepatic动脉输液化疗(HAIC)是晚期肝细胞癌(HCC)的有效治疗选择。 然而,对HAIC的治疗反应很少有人预测因素。 我们澄清了治疗早期最准确的预测因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号